Condensed Consolidating Financial Information (Tables)

12 Months Ended

Dec. 31, 2018

Condensed Financial Information Disclosure [Abstract]

Revision of Previously Issued Financial Statements [Table Text Block]

The impact on our consolidated financial statements are as follows:



Consolidated Balance Sheet
	As Reported			Adjustment			As Revised
As of December 31, 2017	(In Millions)
Deferred income tax assets	$	63.6		$	(29.2	)	$	34.4
Total assets	4,893.7			(29.2		)	4,864.5
Capital in excess of par value	2,791.4			(44.0		)	2,747.4
Accumulated deficit	(1,191.0		)	14.8			(1,176.2		)
Total Encompass Health shareholders’ equity	1,181.7			(29.2		)	1,152.5
Total shareholders’ equity	1,424.6			(29.2		)	1,395.4
Total liabilities and shareholders’ equity	4,893.7			(29.2		)	4,864.5



Consolidated Statement of Operations
	As Reported		Adjustment			As Revised
For the Year Ended December 31, 2017	(In Millions, Except Per Share Data)
Provision for income tax expense	$	160.6	$	(14.8	)	$	145.8
Income from continuing operations	335.8		14.8			350.6
Net income	335.4		14.8			350.2
Net income attributable to Encompass Health	256.3		14.8			271.1
Basic earnings per share attributable to Encompass Health common shareholders	2.73		0.15			2.88
Diluted earnings per share attributable to Encompass Health common shareholders	2.69		0.15			2.84



Consolidated Statement of Comprehensive Income
	As Reported		Adjustment		As Revised
For the Year Ended December 31, 2017	(In Millions)
Net income	$	335.4	$	14.8	$	350.2
Comprehensive income	335.3		14.8		350.1
Comprehensive income attributable to Encompass Health	256.2		14.8		271.0



Consolidated Statement of Shareholders’ Equity
	As Reported			Adjustment			As Revised
For the Year Ended December 31, 2017	(In Millions)
Fair value adjustments to redeemable noncontrolling interests	$	(41.0	)	$	(26.0	)	$	(67.0	)
Capital in excess of par value	2,791.4			(44.0		)	2,747.4
Accumulated deficit	(1,191.0		)	14.8			(1,176.2		)
Total shareholders’ equity	1,424.6			(29.2		)	1,395.4

For the Year Ended December 31, 2016
Fair value adjustments to redeemable noncontrolling interests	$	(6.7	)	$	(4.2	)	$	(10.9	)
Capital in excess of par value	2,799.1			(18.1		)	2,781.0
Total shareholders’ equity	928.7			(18.1		)	910.6

For the Year Ended December 31, 2015
Capital in excess of par value	$	2,834.9		$	(13.9	)	$	2,821.0
Total shareholders’ equity	779.3			(13.9		)	765.4



Consolidated Statement of Cash Flows
	As Reported		Adjustment			As Revised
For the Year Ended December 31, 2017	(In Millions)
Net income	$	335.4	$	14.8		$	350.2
Deferred tax expense	75.6		(14.8		)	60.8

The impact on our condensed consolidating financial statements is as follows:



	Condensed Consolidating Statement of Operations
	For the Year Ended December 31, 2017
	As Reported			Adjustment			As Revised
Encompass Health Corporation	(In Millions)
Provision for income tax expense	$	(90.2	)	$	(14.8	)	$	(105.0	)
Income from continuing operations	256.7			14.8			271.5
Net income	256.3			14.8			271.1
Net income attributable to Encompass Health	256.3			14.8			271.1
Comprehensive income	256.2			14.8			271.0
Comprehensive income attributable to Encompass Health	256.2			14.8			271.0



	Condensed Consolidating Balance Sheet
	As of December 31, 2017
	As Reported		Adjustment			As Revised
Encompass Health Corporation	(In Millions)
Deferred income tax assets	$	97.4	$	(29.2	)	$	68.2
Total assets	3,681.2		(29.2		)	3,652.0
Encompass Health shareholders’ equity	1,181.7		(29.2		)	1,152.5
Total shareholders’ equity	1,181.7		(29.2		)	1,152.5
Total liabilities and shareholders’ equity	3,681.2		(29.2		)	3,652.0

Condensed Consolidating Statement of Operations




	For the Year Ended December 31, 2018
	Encompass Health Corporation			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net operating revenues	$	21.0		$	2,325.6		$	2,061.0		$	(130.3	)	$	4,277.3
Operating expenses:
Salaries and benefits	49.5			1,120.0			1,205.9			(21.4		)	2,354.0
Other operating expenses	37.9			340.7			256.3			(49.8		)	585.1
Occupancy costs	1.9			95.5			39.7			(59.1		)	78.0
Supplies	—			94.7			64.0			—			158.7
General and administrative expenses	161.0			—			59.2			—			220.2
Depreciation and amortization	14.3			106.0			79.4			—			199.7
Government, class action, and related settlements	52.0			—			—			—			52.0
Total operating expenses	316.6			1,756.9			1,704.5			(130.3		)	3,647.7
Interest expense and amortization of debt discounts and fees	124.2			20.6			27.7			(25.2		)	147.3
Other income	(22.4		)	(1.0		)	(4.0		)	25.2			(2.2		)
Equity in net income of nonconsolidated affiliates	—			(7.5		)	(1.2		)	—			(8.7		)
Equity in net income of consolidated affiliates	(465.0		)	(65.8		)	—			530.8			—
Management fees	(153.1		)	112.7			40.4			—			—
Income from continuing operations before income tax (benefit) expense	220.7			509.7			293.6			(530.8		)	493.2
Provision for income tax (benefit) expense	(70.5		)	136.4			53.0			—			118.9
Income from continuing operations	291.2			373.3			240.6			(530.8		)	374.3
Income from discontinued operations, net of tax	1.1			—			—			—			1.1
Net income	292.3			373.3			240.6			(530.8		)	375.4
Less: Net income attributable to noncontrolling interests	—			—			(83.1		)	—			(83.1		)
Net income attributable to Encompass Health	$	292.3		$	373.3		$	157.5		$	(530.8	)	$	292.3
Comprehensive income	$	292.3		$	373.3		$	240.6		$	(530.8	)	$	375.4
Comprehensive income attributable to Encompass Health	$	292.3		$	373.3		$	157.5		$	(530.8	)	$	292.3




	For the Year Ended December 31, 2017
	Encompass Health Corporation			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net operating revenues	$	21.3		$	2,228.0		$	1,790.7		$	(126.1	)	$	3,913.9
Operating expenses:
Salaries and benefits	34.7			1,077.4			1,063.5			(21.0		)	2,154.6
Other operating expenses	32.8			321.8			225.6			(48.6		)	531.6
Occupancy costs	1.9			93.4			34.7			(56.5		)	73.5
Supplies	—			93.2			56.1			—			149.3
General and administrative expenses	143.7			—			28.0			—			171.7
Depreciation and amortization	8.8			103.4			71.6			—			183.8
Total operating expenses	221.9			1,689.2			1,479.5			(126.1		)	3,264.5
Loss on early extinguishment of debt	10.7			—			—			—			10.7
Interest expense and amortization of debt discounts and fees	130.5			21.1			23.8			(21.0		)	154.4
Other (income) loss	(21.7		)	0.2			(3.6		)	21.0			(4.1		)
Equity in net income of nonconsolidated affiliates	—			(7.3		)	(0.7		)	—			(8.0		)
Equity in net income of consolidated affiliates	(341.6		)	(40.3		)	—			381.9			—
Management fees	(145.0		)	108.3			36.7			—			—
Income from continuing operations before income tax (benefit) expense	166.5			456.8			255.0			(381.9		)	496.4
Provision for income tax (benefit) expense	(105.0		)	182.3			68.5			—			145.8
Income from continuing operations	271.5			274.5			186.5			(381.9		)	350.6
Loss from discontinued operations, net of tax	(0.4		)	—			—			—			(0.4		)
Net income	271.1			274.5			186.5			(381.9		)	350.2
Less: Net income attributable to noncontrolling interests	—			—			(79.1		)	—			(79.1		)
Net income attributable to Encompass Health	$	271.1		$	274.5		$	107.4		$	(381.9	)	$	271.1
Comprehensive income	$	271.0		$	274.5		$	186.5		$	(381.9	)	$	350.1
Comprehensive income attributable to Encompass Health	$	271.0		$	274.5		$	107.4		$	(381.9	)	$	271.0




	For the Year Ended December 31, 2016
	Encompass Health Corporation			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net operating revenues	$	20.1		$	2,129.9		$	1,610.5		$	(117.9	)	$	3,642.6
Operating expenses:
Salaries and benefits	45.5			1,006.1			952.6			(18.3		)	1,985.9
Other operating expenses	27.4			309.8			199.7			(46.3		)	490.6
Occupancy costs	2.9			89.8			31.9			(53.3		)	71.3
Supplies	—			89.9			50.1			—			140.0
General and administrative expenses	126.7			—			6.7			—			133.4
Depreciation and amortization	9.4			102.8			60.4			—			172.6
Total operating expenses	211.9			1,598.4			1,301.4			(117.9		)	2,993.8
Loss on early extinguishment of debt	7.4			—			—			—			7.4
Interest expense and amortization of debt discounts and fees	147.3			21.6			23.1			(19.9		)	172.1
Other income	(19.6		)	(0.4		)	(2.8		)	19.9			(2.9		)
Equity in net income of nonconsolidated affiliates	—			(9.0		)	(0.8		)	—			(9.8		)
Equity in net income of consolidated affiliates	(347.2		)	(41.2		)	—			388.4			—
Management fees	(136.2		)	103.1			33.1			—			—
Income from continuing operations before income tax (benefit) expense	156.5			457.4			256.5			(388.4		)	482.0
Provision for income tax (benefit) expense	(91.1		)	182.6			72.4			—			163.9
Income from continuing operations	247.6			274.8			184.1			(388.4		)	318.1
Income from discontinued operations, net of tax	—			—			—			—			—
Net income	247.6			274.8			184.1			(388.4		)	318.1
Less: Net income attributable to noncontrolling interests	—			—			(70.5		)	—			(70.5		)
Net income attributable to Encompass Health	$	247.6		$	274.8		$	113.6		$	(388.4	)	$	247.6
Comprehensive income	$	247.6		$	274.8		$	184.1		$	(388.4	)	$	318.1
Comprehensive income attributable to Encompass Health	$	247.6		$	274.8		$	113.6		$	(388.4	)	$	247.6

Condensed Consolidating Balance Sheet




	As of December 31, 2018
	Encompass Health Corporation		Guarantor Subsidiaries		Nonguarantor Subsidiaries		Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Assets
Current assets:
Cash and cash equivalents	$	41.5	$	2.9	$	24.8	$	—		$	69.2
Restricted cash	—		—		59.0		—			59.0
Accounts receivable, net	—		268.1		199.6		—			467.7
Prepaid expenses and other current assets	36.3		17.5		31.2		(18.8		)	66.2
Total current assets	77.8		288.5		314.6		(18.8		)	662.1
Property and equipment, net	123.9		1,015.3		495.6		—			1,634.8
Goodwill	—		854.6		1,246.2		—			2,100.8
Intangible assets, net	21.4		94.6		327.4		—			443.4
Deferred income tax assets	47.9		28.9		—		(33.9		)	42.9
Other long-term assets	47.9		101.3		141.8		—			291.0
Intercompany notes receivable	535.3		—		—		(535.3		)	—
Intercompany receivable and investments in consolidated affiliates	2,904.4		515.7		—		(3,420.1		)	—
Total assets	$	3,758.6	$	2,898.9	$	2,525.6	$	(4,008.1	)	$	5,175.0
Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of long-term debt	$	35.0	$	6.8	$	11.5	$	(17.5	)	$	35.8
Accounts payable	8.9		46.1		35.0		—			90.0
Accrued payroll	35.0		68.5		84.9		—			188.4
Accrued interest payable	22.3		2.2		0.2		(0.3		)	24.4
Other current liabilities	154.5		4.8		175.6		(1.0		)	333.9
Total current liabilities	255.7		128.4		307.2		(18.8		)	672.5
Long-term debt, net of current portion	2,188.7		235.2		54.7		—			2,478.6
Intercompany notes payable	—		—		535.3		(535.3		)	—
Self-insured risks	16.1		—		103.5		—			119.6
Other long-term liabilities	21.4		17.1		80.9		(33.8		)	85.6
Intercompany payable	—		—		44.7		(44.7		)	—
	2,481.9		380.7		1,126.3		(632.6		)	3,356.3
Commitments and contingencies
Redeemable noncontrolling interests	—		—		261.7		—			261.7
Shareholders’ equity:
Encompass Health shareholders’ equity	1,276.7		2,518.2		857.3		(3,375.5		)	1,276.7
Noncontrolling interests	—		—		280.3		—			280.3
Total shareholders’ equity	1,276.7		2,518.2		1,137.6		(3,375.5		)	1,557.0
Total liabilities and shareholders’ equity	$	3,758.6	$	2,898.9	$	2,525.6	$	(4,008.1	)	$	5,175.0




	As of December 31, 2017
	Encompass Health Corporation		Guarantor Subsidiaries		Nonguarantor Subsidiaries		Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Assets
Current assets:
Cash and cash equivalents	$	34.3	$	2.9	$	17.2	$	—		$	54.4
Restricted cash	—		—		62.4		—			62.4
Accounts receivable, net	—		285.2		186.9		—			472.1
Prepaid expenses and other current assets	61.4		21.7		48.7		(18.5		)	113.3
Total current assets	95.7		309.8		315.2		(18.5		)	702.2
Property and equipment, net	101.8		991.5		423.8		—			1,517.1
Goodwill	—		854.6		1,118.0		—			1,972.6
Intangible assets, net	11.8		105.1		286.2		—			403.1
Deferred income tax assets	68.2		8.4		—		(42.2		)	34.4
Other long-term assets	49.2		100.5		85.4		—			235.1
Intercompany notes receivable	486.2		—		—		(486.2		)	—
Intercompany receivable and investments in consolidated affiliates	2,839.1		311.3		—		(3,150.4		)	—
Total assets	$	3,652.0	$	2,681.2	$	2,228.6	$	(3,697.3	)	$	4,864.5
Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of long-term debt	$	32.8	$	7.4	$	9.6	$	(17.5	)	$	32.3
Accounts payable	10.4		43.5		24.5		—			78.4
Accrued payroll	36.1		63.8		72.2		—			172.1
Accrued interest payable	21.9		2.6		0.2		—			24.7
Other current liabilities	108.8		15.6		86.6		(1.0		)	210.0
Total current liabilities	210.0		132.9		193.1		(18.5		)	517.5
Long-term debt, net of current portion	2,258.5		242.2		44.7		—			2,545.4
Intercompany notes payable	—		—		486.2		(486.2		)	—
Self-insured risks	9.6		—		100.5		—			110.1
Other long-term liabilities	21.4		17.8		78.1		(42.1		)	75.2
Intercompany payable	—		—		144.8		(144.8		)	—
	2,499.5		392.9		1,047.4		(691.6		)	3,248.2
Commitments and contingencies
Redeemable noncontrolling interests	—		—		220.9		—			220.9
Shareholders’ equity:
Encompass Health shareholders’ equity	1,152.5		2,288.3		717.4		(3,005.7		)	1,152.5
Noncontrolling interests	—		—		242.9		—			242.9
Total shareholders’ equity	1,152.5		2,288.3		960.3		(3,005.7		)	1,395.4
Total liabilities and shareholders’ equity	$	3,652.0	$	2,681.2	$	2,228.6	$	(3,697.3	)	$	4,864.5

Condensed Consolidating Statement of Cash Flows



	For the Year Ended December 31, 2018
	Encompass Health Corporation			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net cash (used in) provided by operating activities	$	(10.6	)	$	417.8		$	355.2		$	—		$	762.4
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired	(131.4		)	—			(12.5		)	—			(143.9		)
Purchases of property and equipment	(34.1		)	(133.0		)	(87.4		)	—			(254.5		)
Additions to capitalized software costs	(14.1		)	(0.1		)	(1.8		)	—			(16.0		)
Proceeds from disposal of assets	—			—			0.4			—			0.4
Proceeds from sale of restricted investments	—			—			11.6			—			11.6
Purchases of restricted investments	—			—			(13.3		)	—			(13.3		)
Proceeds from repayment of intercompany note receivable	87.0			—			—			(87.0		)	—
Other	(8.5		)	2.8			(3.1		)	—			(8.8		)
Net cash used in investing activities	(101.1		)	(130.3		)	(106.1		)	(87.0		)	(424.5		)
Cash flows from financing activities:
Principal payments on debt, including pre-payments	(17.6		)	—			(3.0		)	—			(20.6		)
Principal borrowings on notes	—			—			13.2			—			13.2
Principal payments on intercompany note payable	—			—			(87.0		)	87.0			—
Borrowings on revolving credit facility	325.0			—			—			—			325.0
Payments on revolving credit facility	(390.0		)	—			—			—			(390.0		)
Principal payments under capital lease obligations	—			(7.6		)	(10.3		)	—			(17.9		)
Dividends paid on common stock	(100.7		)	—			(0.1		)	—			(100.8		)
Purchase of equity interests in consolidated affiliates	(65.1		)	—			—			—			(65.1		)
Distributions paid to noncontrolling interests of consolidated affiliates	—			—			(75.4		)	—			(75.4		)
Taxes paid on behalf of employees for shares withheld	(7.4		)	—			(0.9		)	—			(8.3		)
Contributions from consolidated affiliates	—			—			12.6			—			12.6
Other	3.0			—			3.1			—			6.1
Change in intercompany advances	371.7			(279.9		)	(91.8		)	—			—
Net cash provided by (used in) financing activities	118.9			(287.5		)	(239.6		)	87.0			(321.2		)
Increase in cash, cash equivalents, and restricted cash	7.2			—			9.5			—			16.7
Cash, cash equivalents, and restricted cash at beginning of year	34.3			2.9			79.6			—			116.8
Cash, cash equivalents, and restricted cash at end of year	$	41.5		$	2.9		$	89.1		$	—		$	133.5

Reconciliation of Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents at beginning of period	$	34.3		$	2.9		$	17.2		$	—		$	54.4
Restricted cash at beginning of period	—			—			62.4			—			62.4
Cash, cash equivalents, and restricted cash at beginning of period	$	34.3		$	2.9		$	79.6		$	—		$	116.8

Cash and cash equivalents at end of period	$	41.5		$	2.9		$	24.8		$	—		$	69.2
Restricted cash at end of period	—			—			59.0			—			59.0
Restricted cash included in other long-term assets at end of period	—			—			5.3			—			5.3
Cash, cash equivalents, and restricted cash at end of period	$	41.5		$	2.9		$	89.1		$	—		$	133.5

Supplemental schedule of noncash financing activity:
Intercompany note activity	$	(136.8	)	$	—		$	136.8		$	—		$	—



	For the Year Ended December 31, 2017
	Encompass Health Corporation			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net cash provided by operating activities	$	28.7		$	381.3		$	248.3		$	—		$	658.3
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired	(10.9		)	—			(27.9		)	—			(38.8		)
Purchases of property and equipment	(39.4		)	(106.1		)	(80.3		)	—			(225.8		)
Additions to capitalized software costs	(16.3		)	(0.2		)	(2.7		)	—			(19.2		)
Proceeds from disposal of assets	—			11.7			0.6			—			12.3
Proceeds from sale of restricted investments	—			—			4.2			—			4.2
Purchases of restricted investments	—			—			(8.5		)	—			(8.5		)
Proceeds from repayment of intercompany note receivable	51.0			—			—			(51.0		)	—
Other	(3.7		)	—			(3.5		)	—			(7.2		)
Net cash used in investing activities	(19.3		)	(94.6		)	(118.1		)	(51.0		)	(283.0		)
Cash flows from financing activities:
Principal payments on debt, including pre-payments	(126.9		)	—			(3.0		)	—			(129.9		)
Principal payments on intercompany notes payable	—			—			(51.0		)	51.0			—
Borrowings on revolving credit facility	273.3			—			—			—			273.3
Payments on revolving credit facility	(330.3		)	—			—			—			(330.3		)
Principal payments under capital lease obligations	—			(6.8		)	(8.5		)	—			(15.3		)
Repurchases of common stock, including fees and expenses	(38.1		)	—			—			—			(38.1		)
Dividends paid on common stock	(91.5		)	—			—			—			(91.5		)
Proceeds from exercising stock warrants	26.6			—			—			—			26.6
Distributions paid to noncontrolling interests of consolidated affiliates	—			—			(51.9		)	—			(51.9		)
Taxes paid on behalf of employees for shares withheld	(19.5		)	—			(0.3		)	—			(19.8		)
Contributions from consolidated affiliates	—			—			20.8			—			20.8
Other	(3.1		)	—			(0.7		)	—			(3.8		)
Change in intercompany advances	313.8			(278.6		)	(35.2		)	—			—
Net cash provided by (used in) financing activities	4.3			(285.4		)	(129.8		)	51.0			(359.9		)
Increase in cash, cash equivalents, and restricted cash	13.7			1.3			0.4			—			15.4
Cash, cash equivalents, and restricted cash at beginning of year	20.6			1.6			79.2			—			101.4
Cash, cash equivalents, and restricted cash at end of year	$	34.3		$	2.9		$	79.6		$	—		$	116.8

Reconciliation of Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents at beginning of period	$	20.6		$	1.6		$	18.3		$	—		$	40.5
Restricted cash at beginning of period	—			—			60.9			—			60.9
Cash, cash equivalents, and restricted cash at beginning of period	$	20.6		$	1.6		$	79.2		$	—		$	101.4

Cash and cash equivalents at end of period	$	34.3		$	2.9		$	17.2		$	—		$	54.4
Restricted cash at end of period	—			—			62.4			—			62.4
Cash, cash equivalents, and restricted cash at end of period	$	34.3		$	2.9		$	79.6		$	—		$	116.8

Supplemental schedule of noncash financing activities:
Intercompany note activity	$	(8.8	)	$	—		$	8.8		$	—		$	—
Conversion of convertible debt	$	319.4		$	—		$	—		$	—		$	319.4



	For the Year Ended December 31, 2016
	Encompass Health Corporation			Guarantor Subsidiaries			Nonguarantor Subsidiaries			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net cash provided by operating activities	$	60.3		$	327.4		$	252.5		$	—		$	640.2
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired	—			—			(48.1		)	—			(48.1		)
Purchases of property and equipment	(21.8		)	(77.4		)	(78.5		)	—			(177.7		)
Additions to capitalized software costs	(22.8		)	(0.2		)	(2.2		)	—			(25.2		)
Proceeds from disposal of assets	—			0.7			23.2			—			23.9
Proceeds from sale of restricted investments	—			—			0.1			—			0.1
Purchases of restricted investments	—			—			(1.3		)	—			(1.3		)
Funding of intercompany note receivable	(22.5		)	—			—			22.5			—
Proceeds from repayment of intercompany note receivable	52.0			—			—			(52.0		)	—
Other	(3.7		)	(0.2		)	2.2			—			(1.7		)
Net cash provided by investing activities of discontinued operations	0.1			—			—			—			0.1
Net cash used in investing activities	(18.7		)	(77.1		)	(104.6		)	(29.5		)	(229.9		)
Cash flows from financing activities:
Principal payments on debt, including pre-payments	(198.5		)	(1.3		)	(2.3		)	—			(202.1		)
Principal borrowings on intercompany notes payable	—			—			22.5			(22.5		)	—
Principal payments on intercompany notes payable	—			—			(52.0		)	52.0			—
Borrowings on revolving credit facility	335.0			—			—			—			335.0
Payments on revolving credit facility	(313.0		)	—			—			—			(313.0		)
Principal payments under capital lease obligations	(0.1		)	(5.9		)	(7.3		)	—			(13.3		)
Repurchases of common stock, including fees and expenses	(65.6		)	—			—			—			(65.6		)
Dividends paid on common stock	(83.8		)	—			—			—			(83.8		)
Distributions paid to noncontrolling interests of consolidated affiliates	—			—			(64.9		)	—			(64.9		)
Taxes paid on behalf of employees for shares withheld	(11.6		)	—			—			—			(11.6		)
Contributions from consolidated affiliates	—			—			3.5			—			3.5
Other	1.1			—			(1.7		)	—			(0.6		)
Change in intercompany advances	274.3			(242.7		)	(31.6		)	—			—
Net cash used in financing activities	(62.2		)	(249.9		)	(133.8		)	29.5			(416.4		)
(Decrease) increase in cash, cash equivalents, and restricted cash	(20.6		)	0.4			14.1			—			(6.1		)
Cash, cash equivalents, and restricted cash at beginning of year	41.2			1.2			65.1			—			107.5
Cash, cash equivalents, and restricted cash at end of year	$	20.6		$	1.6		$	79.2		$	—		$	101.4

Reconciliation of Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents at beginning of period	$	41.2		$	1.2		$	19.2		$	—		$	61.6
Restricted cash at beginning of period	—			—			45.9			—			45.9
Cash, cash equivalents, and restricted cash at beginning of period	$	41.2		$	1.2		$	65.1		$	—		$	107.5

Cash and cash equivalents at end of period	$	20.6		$	1.6		$	18.3		$	—		$	40.5
Restricted cash at end of period	—			—			60.9			—			60.9
Cash, cash equivalents, and restricted cash at end of period	$	20.6		$	1.6		$	79.2		$	—		$	101.4

Supplemental schedule of noncash financing activities:
Intercompany note activity	$	(11.7	)	$	—		$	11.7		$	—		$	—